GxP Best Practices for Safer, Smarter, Faster Clinical Research
GxP guidelines help clinical research meet rigorous standards for safety, quality, and compliance, supporting the development of therapies and medical devices.
GxP guidelines help clinical research meet rigorous standards for safety, quality, and compliance, supporting the development of therapies and medical devices.
Human research protection programs (HRPPs) play a critical role in protecting the rights, safety, and welfare of research participants. A
As research institutions are designing studies and recruiting participants for them, they must maintain compliance and ensure their study is
Single IRB (sIRB) review streamlines oversight for multisite trials, reducing administrative burdens while ensuring participant protections across all sites.
The clinical research industry is only becoming more complex and competitive as organizations are inundated with multiple trials and tight
Rapid growth in gene therapy is expected to receive additional support as the Food and Drug Administration (FDA) Center for
Sites can improve data capture, management, and compliance using a site-centric eSource or EDC platform, supporting smoother workflows, remote monitoring, and efficient data analysis.
When unexpected events occur during the conduct of a clinical trial, research personnel may wonder if the event is reportable,
The Centers for Medicare & Medicaid Services (CMS) released a letter outlining routine costs in clinical trials for patients eligible
Each clinical trial phase builds on the last, from initial safety to post-market studies, ensuring treatments are safe, effective, and beneficial for patients.
Adhering to FDA guidelines is crucial for sponsors and sites to ensure successful inspections, enabling product approvals and faster market access.
Oncology trials face unique hurdles in innovation, enrollment, and endpoints, requiring strategic planning to address complex study demands and precision needs.